November call buyers may like,
BSDM announced today that its exclusive Taiwan distributor Linden Bioscience Co., Ltd. has submitted its BSD-2000 marketing approval application for the BSD2000 Hyperthermia System to the Taiwan Food and Drug Administration (TFDA). The TFDA approval of the BSD-2000 could occur as early as November 2013.
This alone is worth 7.1 million over 5 years. Minimum.
The sellers of those calls did well in hedging during this slow time,
Only time will tell if they expire worthless.